2023
Anti-Müllerian Hormone Level Decline in Patients Undergoing Hysterectomy With and Without Oophorectomy Compared With Natural Menopause
Santoro N, Flyckt R, Davis A, Finkelstein J, Crawford S, Sun F, Derby C, Morrison A, Sluss P, Zhang H. Anti-Müllerian Hormone Level Decline in Patients Undergoing Hysterectomy With and Without Oophorectomy Compared With Natural Menopause. Obstetrics And Gynecology 2023, 141: 331-340. PMID: 36649324, PMCID: PMC9858351, DOI: 10.1097/aog.0000000000005049.Peer-Reviewed Original ResearchConceptsFinal menstrual periodAnti-Müllerian hormone levelsAMH levelsNatural menopauseHormone levelsUndetectable AMH levelsCommunity-based studyOvarian conservationOvarian reserveAMH measurementOvarian failureMenstrual periodSurgery dateHysterectomyLinear mixed modelingMenopauseSurvival analysisPatientsImmediate reductionMixed modelingWomenOvariesSimilar patternRapid declineBSO
2022
A personalized medicine approach to ovulation induction/ovarian stimulation: development of a predictive model and online calculator from level-I evidence
Souter I, Sun F, Zhang H, Diamond MP, Legro RS, Wild RA, Hansen KR, Santoro N, Network F. A personalized medicine approach to ovulation induction/ovarian stimulation: development of a predictive model and online calculator from level-I evidence. Fertility And Sterility 2022, 117: 408-418. PMID: 35125179, PMCID: PMC8985501, DOI: 10.1016/j.fertnstert.2021.10.024.Peer-Reviewed Original ResearchMeSH KeywordsAdultBody Mass IndexClinical Decision-MakingCoitusDecision Support TechniquesFemaleFertilityFertility Agents, FemaleHumansInfertility, FemaleInsemination, ArtificialMaleMaternal AgeOvulation InductionPolycystic Ovary SyndromePrecision MedicinePregnancyPregnancy RateRandomized Controlled Trials as TopicRisk AssessmentRisk FactorsTreatment OutcomeConceptsCumulative pregnancy rateAntimüllerian hormone levelsBody mass indexMultiple pregnanciesPregnancy rateClinical pregnancyOvulation inductionOvarian responseMedication doseMass indexHormone levelsLower body mass indexPregnancy rate/cyclePartner ageHigh antral follicle countLower medication doseMultiple Intrauterine GestationsMultiple pregnancy rateAntral follicle countPolycystic ovary syndromeCharacteristic curveMultivariable regression modelsPersonalized medicine approachGonadotropin useIndividualized chance
2020
Embryo cryopreservation and utilization in the United States from 2004–2013
Christianson MS, Stern JE, Sun F, Zhang H, Styer AK, Vitek W, Polotsky AJ. Embryo cryopreservation and utilization in the United States from 2004–2013. F&S Reports 2020, 1: 71-77. PMID: 34223221, PMCID: PMC8244341, DOI: 10.1016/j.xfre.2020.05.010.Peer-Reviewed Original ResearchART cyclesFresh cyclesAssisted Reproductive Technology Clinical Outcomes Reporting SystemEmbryo transferSubsequent frozen embryo transferDonor oocyte cyclesAntimüllerian hormone levelsDiminished ovarian reserveFrozen embryo transferReproductive technology clinicsPreimplantation genetic testingAssisted Reproductive TechnologyNumber of embryosPercentage of womenOocyte cyclesOvarian reserveHistorical cohortHormone levelsRegistry dataRetrospective analysisTechnology clinicsGenetic testingExcess embryosEmbryo cryopreservationFrozen embryos
2019
Lower antimüllerian hormone is associated with lower oocyte yield but not live-birth rate among women with obesity
Vitek W, Sun F, Baker VL, Styer AK, Christianson MS, Stern JE, Zhang H, Polotsky AJ. Lower antimüllerian hormone is associated with lower oocyte yield but not live-birth rate among women with obesity. American Journal Of Obstetrics And Gynecology 2019, 222: 363.e1-363.e7. PMID: 31589862, PMCID: PMC8022853, DOI: 10.1016/j.ajog.2019.09.046.Peer-Reviewed Original ResearchConceptsNormal body mass indexAntimüllerian hormone levelsLower antimüllerian hormoneBody mass indexLower oocyte yieldLive birth rateAntimüllerian hormoneLow ovarian reserveOocyte yieldMass indexHormone levelsOvarian reserveBody mass index 18.5Low antimüllerian hormone levelsAssisted Reproductive Technology Clinic Outcome Reporting System databaseLower live birth ratesClass 3 obesitySerum antimüllerian hormoneClass 1 obesityClass 2 obesityNumber of oocytesSmall antral folliclesReporting System databaseNormal BMIRetrospective cohort